Top 5 ob/gyn news stories of 2018

December 12, 2018

From a controversial contraceptive being taken off the market to IVF storage tank failures, these were the top ob/gyn news stories of the year.

From a controversial contraceptive being taken off the market to IVF storage tank failures, these were the top ob/gyn news stories of the year.

Sales of controversial contraceptive implant to end

Following FDA restrictions on sales and distribution of Essure, Bayer announced in July that it would discontinue U.S. sales of Essure at the end of 2018.

©mypokclik/Shutterstock.com

IVF storage tank failures spark reviews, lawsuits

In May, the failure of liquid nitrogen storage tanks at two major infertility centers led to a review of procedures at those and other similar facilities by them and the American Society for Reproductive Medicine (ASRM).

©Jomwaschara_Komvorn/shutterstock.com

Panel issues guidelines for perimenopausal depression

In September, the first-ever guidelines for perimenopausal depression were developed by The North American Menopause Society and the National Network on Depression Centers Women and Mood Disorders Task Group.

©EtiAmmos/shutterstock.com

Does minimally invasive surgery for cervical cancer = longer survival?

In November, the results of a cohort study suggested thatminimally invasive and open surgeries may not produce similar survival rates for early cervical cancer.

Another gene-edited embryo in China?

In December, South China Morning Post published a video of Chinese scientist, He Jiankui, made during a conference in Hong Kong, in which he said that a second woman may be pregnant with an embryo that he genetically modified using CRISPR-Cas9.